TNFRSF10A and Alzheimer disease: Elucidating the post-DR4 signaling pathways that can potentiate the γ oscillation-enhancing effect of DA, may identify potential targets for cognition-boosting therapies in normal aging and aging-related diseases like Alzheimer’s disease.